April 02, 2025

GLP-1 Spending Surged 500% Since 2018

U.S. spending on GLP-1 receptor agonists reached $71.7 billion in 2023. Semaglutide and tirzepatide products have captured 70% of the market as diabetes and weight loss medication use rapidly expands, according to new research.

Conexiant

April 01, 2025

GEM Helps Put T2D in Remission

Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.

Conexiant

April 01, 2025

A Different Perspective on an Age-Old Disease

Discover how Optical Coherence Tomography (OCT) technology can revolutionize the management of posterior segment diseases in this engaging editorial content by Dr. James L. Fanelli.

Optometric Management

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

April 01, 2025

Coding Q&A: Coding Guidelines for Wet AMD

Ensure compliance and prompt payment by using proper ICD-10-CM codes for diagnosing patients with exudative age-related macular degeneration (wet AMD). Learn the guidelines for coding specific eye conditions and disease stages.

Retinal Physician

March 31, 2025

Microplastics Linked to Cardiovascular Disease

Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.

Conexiant

March 31, 2025

Hormone Therapy Boosts Semaglutide Weight Loss

At 12 months, women on hormone therapy achieved 16% total body weight loss with semaglutide, compared to 12% in those not using hormone therapy, researchers reported.

Conexiant

March 31, 2025

Long-Term Antidepressant Use Affects Body Weight

"Given the global obesity epidemic and the widespread use of antidepressants, weight management and metabolic monitoring should be encouraged and integrated into depression follow-up guidelines alongside antidepressant prescriptions," the researchers concluded.

Conexiant

March 28, 2025

Mango Intake Linked to Improved Insulin Sensitivity

Fasting insulin levels were significantly lower with mango intake, according to a new study.

Conexiant